Skyepharma Plc (SKYEY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 40,211 | -17,300 | 1,250 | -6,970 | N/A |
| Depreciation Amortization | 4,281 | 5,270 | 6,720 | 4,750 | N/A |
| Income taxes - deferred | 5,351 | 0 | 0 | 0 | N/A |
| Accounts receivable | -306 | 0 | 0 | 0 | N/A |
| Accounts payable and accrued liabilities | -917 | 0 | 0 | 0 | N/A |
| Other Working Capital | -14,372 | 4,940 | -3,910 | 150 | N/A |
| Other Operating Activity | 4,281 | 56,360 | 18,160 | 31,070 | 0 |
| Operating Cash Flow | $38,530 | $49,270 | $22,220 | $29,000 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,351 | -1,810 | -3,590 | -790 | N/A |
| Net Acquisitions | N/A | 0 | 0 | 9,820 | N/A |
| Purchase Sale Intangibles | -1,529 | 0 | 0 | 0 | N/A |
| Other Investing Activity | -1,376 | -2,800 | -1,570 | -320 | 0 |
| Investing Cash Flow | $-6,727 | $-4,610 | $-5,160 | $8,710 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -17,277 | 0 | 0 | 0 | N/A |
| Other Financing Activity | -2,599 | -18,290 | -16,890 | -35,660 | 0 |
| Financing Cash Flow | $-19,876 | $-18,290 | $-16,890 | $-35,660 | $N/A |
| Exchange Rate Effect | 1,376 | -160 | 0 | -150 | N/A |
| Beginning Cash Position | 49,538 | 26,200 | 25,660 | 24,090 | N/A |
| End Cash Position | 62,840 | 53,390 | 25,810 | 25,990 | N/A |
| Net Cash Flow | $13,302 | $27,190 | $150 | $1,900 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 38,530 | 49,270 | 22,220 | 29,000 | N/A |
| Capital Expenditure | -5,351 | 0 | 0 | 0 | N/A |
| Free Cash Flow | 33,178 | 49,270 | 22,220 | 29,000 | 0 |